Skip to main content

Year: 2025

Third quarter 2025 update: IBA is highly confident to meet FY2025 guidance, and strengthens financing structure

Louvain-la-Neuve, Belgium, 20 November 2025 – IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025. Group OverviewEquipment order intake at €195 million as of Q3 2025 (+6% vs. last year) with a strong contribution from IBA Technologies (+22%) driven by RadioPharma Solutions, and four Proteus®ONE solutions sold within IBA Clinical.   Equipment and Services backlog stable at €1.3 billion, with sustained backlog conversion. FY2025 REBIT guidance confirmed: at least €25 million, supported by well under control OpEx and an already positive REBIT contribution from Proton Therapy. At net result level, financials continue to be impacted by foreign exchange fluctuations (primarily USD and CNY). Net debt position at €60 million1 as of September 30,...

Continue reading

Corbion unveils BRIGHT 2030 strategy to lead in sustainable specialty food-ingredients; outlining its strategic path and medium-term financial targets

Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, will hold its Capital Markets Day for analysts and investors via live webcast and in-person in Gorinchem, the Netherlands today. Corbion management will present its strategy for the period 2026-2030: BRIGHT 2030, a new strategy designed to lead the way in sustainable specialty food ingredients for preservation and nutrition. BRIGHT 2030: Key strategic prioritiesAccelerate clean-label preservation and formulation in food, responding to increasing consumer demand for transparency and natural solutionsExpand algal fermentation beyond omega-3 oils, unlocking new opportunities in pet food and human nutrition Foster growth in Biomedical Polymers, reinforcing Corbion’s presence in high-value healthcare applicationsStrategic...

Continue reading

MoneyHero and Coinbase Jointly Publish Pulse of Crypto — Singapore 2025 Survey Report

61% of finance-forward Singaporeans hold cryptocurrency Trust emerges as primary factor in exchange selection, outranking fees 58% of crypto-curious Singaporeans prefer holding crypto over trading 42% of holders have been invested for >2 years.SINGAPORE, Nov. 20, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today jointly published the Pulse of Crypto — Singapore 2025 survey report with Coinbase Global, Inc. (NASDAQ: COIN). The survey examined crypto ownership, attitudes and market maturity in Singapore. It surveyed 3,513 active retail investors and members of the wider crypto-curious public in Singapore between 15–19 August 2025. The...

Continue reading

MINILUXE REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND YTD Q3 2025

The Company Announces Continued Double-Digit System-Wide Sales Growth and 10 consecutive quarters of Unit Economic Improvement Reported figures are all in U.S. Dollars Boston, MA, Nov. 19, 2025 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 13 and 39 weeks ended September 28, 2025 (“Q3 2025” and “YTD Q3 2025”). The fiscal year of MiniLuxe (“The Company”) is a 52-week reporting cycle ending on the Sunday closest to December 31, which periodically necessitates a fiscal year of 53 weeks; fiscal years referred to in this release consist of 52-week periods. Unless otherwise specified, all amounts are reported in U.S. dollars. MiniLuxe aims to be the leading lifestyle brand in the areas of nail care and related self-care services and products. The Company’s purpose is...

Continue reading

Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID’s New AI-Powered Feature

TORBAL DIVISION SALES UP 15% YTDLAUNCH OF VIVID’S FIRST AI-POWERED FEATURESECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26 Investor Call to be held Thursday, November 20th at 11:00 a.m. Eastern Time BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — Scientific Industries, Inc. (OTCQB: SCND), a leading developer of digitally simplified bioprocessing solutions and vision-based pill counters, today reported financial results for the three and nine months ended September 30, 2025, and announced the launch of a new AI-enabled feature for its VIVID WORKSTATION. Business Highlights:Launched an innovative prescription label documentation and verification feature for the VIVID WORKSTATION, harnessing AI technology Achieved a 27% year-over-year sales increase for VIVID products Torbal Division sales up 15% year-over-year DOTS MPS...

Continue reading

Brookfield Infrastructure Corporation Announces At-the-Money Equity Issuance Program

All amounts in U.S. dollars BROOKFIELD, NEWS, Nov. 19, 2025 (GLOBE NEWSWIRE) — Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) (“BIPC”) today announced that it has made the necessary Canadian and U.S. securities filings to enable an “at the market” equity issuance program (the “ATM Program”). Under the ATM Program, BIPC may, at its discretion, offer and sell up to $400 million (or the Canadian dollar equivalent) of class A exchangeable subordinate voting shares (the “BIPC Shares”) directly from treasury. These shares may be sold to the public from time to time at prevailing market prices through the Toronto Stock Exchange, the New York Stock Exchange or any other marketplace in Canada or the United States where BIPC Shares may be traded. As a result, sale prices of the BIPC Shares sold under the ATM Program, if any,...

Continue reading

JOYY Reports Third Quarter 2025 Unaudited Financial Results

SINGAPORE, Nov. 20, 2025 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Financial Highlights1Net revenues were US$540.2 million, compared with US$558.7 million in the corresponding period of 2024, representing an increase of 6.4% from US$507.8 million in the second quarter of 2025.Live streaming revenues were US$388.5 million, compared with US$439.5 million in the corresponding period of 2024, representing an increase of 3.5% from US$375.4 million in the second quarter of 2025. Advertising revenues2 increased by 29.2% to US$112.5 million from US$87.1 million in the corresponding period of 2024 and by 17.1% from US$96.1 million in the second quarter of 2025. Other revenues increased...

Continue reading

FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the closing of its previously announced issuance and sale to an existing shareholder of 3,540,000 shares of its common stock and pre-funded warrants to purchase 8,570,203 shares of its common stock at a purchase price of $0.3303 per share or pre-funded warrant (less $0.00001 for each pre-funded warrant), in a registered direct offering priced at-the-market under Nasdaq rules. The pre-funded warrants are exercisable at any time at an exercise price of $0.00001 per share and do not expire. The...

Continue reading

Magnera Reports Fourth Quarter and Fiscal Year Results

CHARLOTTE, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) — Fourth Quarter HighlightsGAAP: Net sales of $839 million, Operating income of $10 million Non-GAAP: Adjusted EBITDA of $90 million Record cash flow with cash from operations of $96 million $50 million term loan repaymentFiscal Year HighlightsGAAP: Net sales of $3.2 billion, Operating income of $5 million Non-GAAP: Adjusted EBITDA of $362 million ($354 million reported and pre-merger $8 million October) Post-merger adjusted free cash flow $126 million represents a yield of over 30% as of year-end Year-end leverage of 3.8xCurt Begle, Magnera’s CEO, commented: “I am very proud of what our team has accomplished not only this quarter but over the entire year. More than a year ago, we launched Magnera with a bold vision and a deep belief in what we could build together as an...

Continue reading

Montage Gold announces that its Petit Yao target has the potential to become a higher-grade satellite of scale

HIGHLIGHTS: Recent drill results from the Petit Yao target, located near the Koné processing plant, highlight its potential to be delineated into one of the project’s highest-grade satellite deposits of scale Initial drill results from the ongoing programme include the following high-grade intercepts:6.0m at 7.26 g/t Au from 55m 6.0m at 5.09 g/t Au from 59m 5.0m at 5.12 g/t Au from 43mMineralisation has been confirmed at the Petit Yao target over a strike length of over 1.1km and to a depth of only 150 meters, with mineralization open in all directions Efforts are now prioritizing the Petit Yao target with a further 6,800m to be completed before year end, up from 4,068m YTD, in addition to 1,000m of scout drilling commencing on a soil geochemical anomaly located northeast of Petit Yao Maiden resource at Petit Yao is expected...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.